Drug-development and commercialization
Active 2008–2010.
| Year | Firm | Period | Amount | Doc |
|---|---|---|---|---|
| 2010 | STRATEGIC MARKETING INNOVATIONS |
2nd Quarter (Apr 1 - June 30) AMENDED |
$10,000 | |
| 2010 | STRATEGIC MARKETING INNOVATIONS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$10,000 | |
| 2010 | STRATEGIC MARKETING INNOVATIONS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$10,000 | |
| 2009 | STRATEGIC MARKETING INNOVATIONS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$10,000 | |
| 2009 | STRATEGIC MARKETING INNOVATIONS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$15,000 | |
| 2009 | STRATEGIC MARKETING INNOVATIONS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$15,000 | |
| 2009 | STRATEGIC MARKETING INNOVATIONS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$15,000 | |
| 2008 | STRATEGIC MARKETING INNOVATIONS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$5,000 | |
| 2008 | STRATEGIC MARKETING INNOVATIONS |
4th Quarter (Oct 1 - Dec 31) Registration |
— |
| Firm | Filings | Amount |
|---|---|---|
| STRATEGIC MARKETING INNOVATIONS | 9 | $80,000 |
| Issue | Activities |
|---|---|
| Defense | 9 |